Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 132,244 | 89,833 | -209,409 | -238,286 | -127,788 |
| Depreciation Amortization | 2,888 | 3,259 | 3,235 | 3,398 | 2,996 |
| Accounts receivable | -15,218 | -141,992 | N/A | 1,859 | -299 |
| Accounts payable and accrued liabilities | -9,820 | 9,893 | -534 | -4,454 | -7,636 |
| Other Working Capital | -34,651 | -112,534 | 10,297 | -5,133 | -159,214 |
| Other Operating Activity | 78,702 | 179,896 | 37,145 | 42,330 | 39,396 |
| Operating Cash Flow | $154,145 | $28,355 | $-159,266 | $-200,286 | $-252,545 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,231 | -1,822 | -789 | -4,573 | -6,515 |
| Net Acquisitions | 175 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -273,845 | -20,235 | -42,869 | -74,344 | N/A |
| Sale Of Investment | 274,000 | 20,400 | 43,170 | 74,500 | N/A |
| Other Investing Activity | -7,500 | -11,075 | -700 | 0 | 0 |
| Investing Cash Flow | $-14,401 | $-12,732 | $-1,188 | $-4,417 | $-6,515 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 222,156 | N/A | N/A | N/A | 100,000 |
| Debt Repayment | -18,170 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 17,428 | 13,711 | 103,830 | 482 | 126,918 |
| Common Stock Repurchased | 3,801 | 3,519 | N/A | N/A | N/A |
| Other Financing Activity | -1,269 | 72,140 | 1,591 | 206,305 | -739 |
| Financing Cash Flow | $223,946 | $89,370 | $105,421 | $206,787 | $226,179 |
| Exchange Rate Effect | N/A | -276 | 468 | -120 | -398 |
| Beginning Cash Position | 177,908 | 73,191 | 127,756 | 125,792 | 159,071 |
| End Cash Position | 541,598 | 177,908 | 73,191 | 127,756 | 125,792 |
| Net Cash Flow | $363,690 | $104,717 | $-54,565 | $1,964 | $-33,279 |
| Free Cash Flow | |||||
| Operating Cash Flow | 154,145 | 28,355 | -159,266 | -200,286 | -252,545 |
| Capital Expenditure | -7,231 | -1,822 | -789 | -4,573 | -6,515 |
| Free Cash Flow | 146,914 | 26,533 | -160,055 | -204,859 | -259,060 |